Latest filing published 16 May 2025 for Lantheus Holdings, Inc..
Insider track record
No signal scores available.
Phuong Khanh Morrow: trading record in brief
Phuong Khanh Morrow discloses dealings in 2 companies, chiefly CRISPR Therapeutics AG and Lantheus Holdings, Inc. The record holds 4 filings, for trades running from 23 May 2023 to 14 May 2025.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 16 May 2025, the filings show a share grant in Lantheus Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Phuong Khanh Morrow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,537 shares0Common StockSEC:0001062993-25-009698:0
- 563 shares0Common StockSEC:0001062993-25-002103:0
- 2,527 shares@ US$65.91100.0% of flowCommon SharesSEC:0001209191-23-032250:1
- 6,938 sharesCommon SharesSEC:0001209191-23-032250:0
4 of 4 declarations
